📍 1 Triton Square, London NW1 3BF
Over the past few years, TechBio has accounted for over 40% of all UK biotech deals, securing more than £2.6 billion in capital between 2020 and 2024, with major investments from innovators like Isomorphic Labs and Recursion.
A flurry of high-value deals at the end of 2025 showed the sector’s momentum is stronger than ever, and 2026 is shaping up to be an exciting year with renewed overseas interest, particularly from the US.
The TechBio Shift, co-hosted by The Knowledge Quarter and Venture Café London, is a relaxed space for industry leaders, investors and entrepreneurs to share stories, spark ideas, and explore what’s next in innovation and growth.
Come for the insights, stay for the connections, and leave inspired about the future of UK TechBio.
Powered by Advanced Research + Invention Agency
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
We're excited to welcome a brilliant lineup of biotech startups:
- Storegene - Affordable, accessible & actionable genomics.
- Neurolase - Revolutionising Neurosurgical safety and precision.
- Cam Med - An AI-powered RNA platform to unlock safer, faster, easier medicines.
- Vivantx - Bespoke cancer treatment recommendations.
- Jiva.ai - delivers value to businesses that will ultimately benefit from an enhanced and democratised Data Science & AI as a service.
- Houdini Bio - Re-designing DNA with computational synthetic biology for durable, scalable performance.
- deepmirror AI - AI for hit-to-candidate molecule design.
- Precision Life - Solving chronic disease with world-leading precision medicine AI.
- Engivent - Programmable microfluidics for autonomous biology labs.
- South West Biotech - Where biology meets collaboration.
- Twinvitro.bio - Engineering clinical certainty with human cellular models.
This is for early-stage bio and life-science founders who would like practical tactics on applied AI.
Your chance to ask: how to use AI coding agents like Claude Code in a biotech context; how to automate a work cell and start training your own model; how to pick the right model for the problem you actually have; an intro to AI for a founder who has been too busy to catch up; how to integrate AI into your team's workflow. Bring a real question and leave with something you can try this week!
Introduction from Venture Café London and the Knowledge Quarter.
Biology and human health are being redesigned. London is home to some of the most exciting work happening in the UK’s R&D landscape. But ambition alone doesn't build an industry.
With life sciences being a designated UK growth sector, we’re finally seeing the policy environment shifting to match - with the Life Sciences Innovative Manufacturing Fund committing £520 million to biomanufacturing scale-up, a new UK-US pharmaceuticals accord removing trade barriers for British-made medicines, and a wholesale rethink of how innovation gets funded at every stage. The conditions for TechBio have arguably never been more deliberate.
This panel brings together innovators, operators, and investors to move beyond the headlines and take an honest look at where London's TechBio ecosystem really stands, and what it will take to turn world-class science into lasting, scalable impact.
Great Ormond Street Hospital (GOSH) is partnering with LifeArc, a charity dedicated to rare disease research, to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.
The project will drive the secure use of health data to develop insights and breakthroughs that could turbocharge rare disease research and help the thousands of children diagnosed with rare diseases every year in the UK.
Rare disease health data is often fragmented and disconnected due to small numbers living with the conditions, which can hold back research. There is an urgent need for change with more than three million people in the UK living with a rare disease, and approximately 70 per cent of those diseases affecting children. Currently 95 per cent of rare diseases have no approved treatments. Join us for a fireside chat on the project so far.
📍 1 Triton Square, London NW1 3BF
Over the past few years, TechBio has accounted for over 40% of all UK biotech deals, securing more than £2.6 billion in capital between 2020 and 2024, with major investments from innovators like Isomorphic Labs and Recursion.
A flurry of high-value deals at the end of 2025 showed the sector’s momentum is stronger than ever, and 2026 is shaping up to be an exciting year with renewed overseas interest, particularly from the US.
The TechBio Shift, co-hosted by The Knowledge Quarter and Venture Café London, is a relaxed space for industry leaders, investors and entrepreneurs to share stories, spark ideas, and explore what’s next in innovation and growth.
Come for the insights, stay for the connections, and leave inspired about the future of UK TechBio.
Powered by Advanced Research + Invention Agency
Our Thursday Gatherings are for you to make serendipitous connections and make things happen!
There will be meaningful networking opportunities throughout the night, accompanied by a selection of refreshments and activities:
Fun Zone
Get to know your fellow change-makers in a fun, interactive, and exciting way!
Take a quick break from changing the world and recharge by pinning your hometown on our giant map.
Conversation Corner
Looking to connect beyond the name tags?
Drop into our relaxed Conversation Corner, a cosy space where founders, ecosystem builders, and global thinkers come together to share stories, swap lessons, and innovate. Grab a drink, pull up a chair, and jump into the discussion.
We're excited to welcome a brilliant lineup of biotech startups:
- Storegene - Affordable, accessible & actionable genomics.
- Neurolase - Revolutionising Neurosurgical safety and precision.
- Cam Med - An AI-powered RNA platform to unlock safer, faster, easier medicines.
- Vivantx - Bespoke cancer treatment recommendations.
- Jiva.ai - delivers value to businesses that will ultimately benefit from an enhanced and democratised Data Science & AI as a service.
- Houdini Bio - Re-designing DNA with computational synthetic biology for durable, scalable performance.
- deepmirror AI - AI for hit-to-candidate molecule design.
- Precision Life - Solving chronic disease with world-leading precision medicine AI.
- Engivent - Programmable microfluidics for autonomous biology labs.
- South West Biotech - Where biology meets collaboration.
- Twinvitro.bio - Engineering clinical certainty with human cellular models.
This is for early-stage bio and life-science founders who would like practical tactics on applied AI.
Your chance to ask: how to use AI coding agents like Claude Code in a biotech context; how to automate a work cell and start training your own model; how to pick the right model for the problem you actually have; an intro to AI for a founder who has been too busy to catch up; how to integrate AI into your team's workflow. Bring a real question and leave with something you can try this week!
Introduction from Venture Café London and the Knowledge Quarter.
Biology and human health are being redesigned. London is home to some of the most exciting work happening in the UK’s R&D landscape. But ambition alone doesn't build an industry.
With life sciences being a designated UK growth sector, we’re finally seeing the policy environment shifting to match - with the Life Sciences Innovative Manufacturing Fund committing £520 million to biomanufacturing scale-up, a new UK-US pharmaceuticals accord removing trade barriers for British-made medicines, and a wholesale rethink of how innovation gets funded at every stage. The conditions for TechBio have arguably never been more deliberate.
This panel brings together innovators, operators, and investors to move beyond the headlines and take an honest look at where London's TechBio ecosystem really stands, and what it will take to turn world-class science into lasting, scalable impact.
Great Ormond Street Hospital (GOSH) is partnering with LifeArc, a charity dedicated to rare disease research, to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.
The project will drive the secure use of health data to develop insights and breakthroughs that could turbocharge rare disease research and help the thousands of children diagnosed with rare diseases every year in the UK.
Rare disease health data is often fragmented and disconnected due to small numbers living with the conditions, which can hold back research. There is an urgent need for change with more than three million people in the UK living with a rare disease, and approximately 70 per cent of those diseases affecting children. Currently 95 per cent of rare diseases have no approved treatments. Join us for a fireside chat on the project so far.